This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
B of A Securities downgrades several stocks, including Liquidia Corp.
Top Wall Street analysts changed their outlook on these top names.
For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
B of A Securities analyst Allen Lutz downgraded Doximity Inc (NYSE: DOCS ) from Buy to Underperform and cut the price target from $38 to $20.
Doximity shares closed at $20.88 on Friday.
See how other analysts view this stock.
B of A Securities analyst Jason Gerberry downgraded Amphastar Pharmaceuticals, Inc (NASDAQ: AMPH ) from Neutral to Underperform and lowered the price target from $25 to $20.
Amphastar Pharma shares closed at $21.78 on Friday.
See how other analysts view this stock.
Seaport Global analyst David Joyce downgraded Madison Square Garden Entertainment Corp (NYSE: MSGE ) from Buy to Neutral.
Madison Square Garden shares closed at $80.30 on Friday.
See how other analysts view this stock.
B of A Securities analyst Jason Gerberry downgraded Liquidia Corp (NASDAQ: LQDA ) from Buy to Neutral and raised the price target from $64 to $79.
Liquidia shares closed at $78.17 on Friday.
See how other analysts view this stock.
B of A Securities analyst Jason Gerberry downgraded Alkermes Plc (NASDAQ: ALKS ) from Neutral to Underperform and announced a $38 price target.
Alkermes shares closed at $55.08 on Friday.
See how other analysts view this stock.
Considering buying LQDA stock? Here’s what analysts think: Photo via Shutterstock